Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4+ T Cells and Peripheral Blood from Tuberculosis Patients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kleinsteuber, Katja ^a   Heesch, Kerrin ^a   Schattling, Stefanie ^a   Kohns, Malte ^b   Sander Jülch, Claudia ^a   Walzl, Gerhard ^c   Hesseling, Anneke ^c   Mayatepek, Ertan ^b   Fleischer, Bernhard ^a   Marx, Florian M ^d   Jacobsen, Marc ^a,b  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; GAMMA INTERFERON; INTERLEUKIN 17; MICRORNA; MICRORNA 142 3P; MICRORNA 21; MICRORNA 26A; MICRORNA 29A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFANT; LATENT TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TUBERCULOSIS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LATENT TUBERCULOSIS; MALE; MICRORNAS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84876191502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061609     Document Type: Article

References (42)

1. Dorhoi A, Reece ST, Kaufmann SH, (2011) For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol Rev 240: 235-251.
2. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, et al. (2009) Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 182: 8047-8055.
3. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
4. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17: 372-376.
5. Day CL, Abrahams DA, Lerumo L, Janse van Rensburg E, Stone L, et al. (2011) Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 187: 2222-2232.
6. Wozniak TM, Saunders BM, Ryan AA, Britton WJ, (2010) Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 78: 4187-4194.
7. Chen X, Zhang M, Liao M, Graner MW, Wu C, et al. (2010) Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 181: 734-742.
8. Kumar NP, Anuradha R, Suresh R, Ganesh R, Shankar J, et al. (2011) Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children. Clin Vaccine Immunol 18: 1856-1864.
9. Marin ND, Paris SC, Rojas M, Garcia LF, (2012) Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis. Clin Vaccine Immunol 19: 1667-1676.
10. Jurado JO, Pasquinelli V, Alvarez IB, Pena D, Rovetta AI, et al. (2012) IL-17 and IFN-gamma expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol 91: 991-1002.
11. Basile JI, Geffner LJ, Romero MM, Balboa L, Sabio YGC, et al. (2011) Outbreaks of mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load. J Infect Dis 204: 1054-1064.
12. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD, (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845.
13. Sun W, Julie Li YS, Huang HD, Shyy JY, Chien S, (2010) microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng 12: 1-27.
14. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D, (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10: 111-122.
15. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, et al. (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91.
16. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, et al. (2010) An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115: 265-273.
17. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, et al. (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
18. Mattes J, Collison A, Plank M, Phipps S, Foster PS, (2009) Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 106: 18704-18709.
19. Wei B, Pei G, (2010) microRNAs: critical regulators in Th17 cells and players in diseases. Cell Mol Immunol 7: 175-181.
20. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK,et al. MicroRNA-21 Limits In Vivo Immune Response-Mediated Activation of the IL-12/IFN-{gamma} Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity. J Immunol.
21. Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, et al. (2011) MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-gamma Production in Helper T Cells. Immunity 35: 169-181.
22. Ma F, Xu S, Liu X, Zhang Q, Xu X, et al. (2011) The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 12: 861-869.
23. Tili E, Michaille JJ, Calin GA, (2008) Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 5: 73-79.
24. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
25. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2006) Deconfounding microarray analysis- independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias. Methods Inf Med 45: 557-563.
26. Haasch D, Chen YW, Reilly RM, Chiou XG, Koterski S, et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 217: 78-86.
27. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178: 2243-2247.
28. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
29. Ottenhoff TH, De Boer T, van Dissel JT, Verreck FA, (2003) Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv Exp Med Biol 531: 279-294.
30. Buckler JL, Liu X, Turka LA, (2008) Regulation of T-cell responses by PTEN. Immunol Rev 224: 239-248.
31. Bui TV, Mendell JT, (2010) Myc: Maestro of MicroRNAs. Genes Cancer 1: 568-575.
32. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, et al. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
33. Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, et al. (2010) Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110: 1155-1164.
34. Buechner J, Henriksen JR, Haug BH, Tomte E, Flaegstad T, et al. (2011) Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells. Differentiation 81: 25-34.
35. Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner S, et al. (2011) Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients. Clin Microbiol Infect 17: 1323-1331.
36. Kumar P, Verma A, Saini AK, Chopra P, Chakraborti PK, et al. (2005) Nucleoside diphosphate kinase from Mycobacterium tuberculosis cleaves single strand DNA within the human c-myc promoter in an enzyme-catalyzed reaction. Nucleic Acids Res 33: 2707-2714.
37. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, et al. (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 12: 796-803.
38. Buckler JL, Walsh PT, Porrett PM, Choi Y, Turka LA, (2006) Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J Immunol 177: 4262-4266.
39. Huang G, Redelman-Sidi G, Rosen N, Glickman MS, Jiang X, (2012) Inhibition of mycobacterial infection by the tumor suppressor PTEN. J Biol Chem 287: 23196-23202.
40. Kleinsteuber K, Heesch K, Schattling S, Sander-Juelch C, Mock U, et al. (2012) SOCS3 promotes interleukin-17 expression of human T cells. Blood 120: 4374-4382.
41. Mueller H, Detjen AK, Schuck SD, Gutschmidt A, Wahn U, et al. (2008) Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 43: 143-148.
42. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2005) Ras-associated small GTPase 33A, a novel T cell factor, is down-regulated in patients with tuberculosis. J Infect Dis 192: 1211-1218.